KILLEEN MATTHEW (Chief Scientific Officer) reported 1 transaction at RENOVACOR, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/5/2022ACC: 0001062993-22-023382
Officer· Chief Scientific Officer
Since Sep 2021
-209.87K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
209.87K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.28K
Price / share
—
Trade value
—
% of position
New position
12/1/2022
5.28K→0.00
Total
Net shares
−5.28K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/1/2022 | D · Disposition | −5.28K | — | — | New position | 5.28K | 0.00 |
| Total | −5.28K | $0.00 | ||||||
Derivative Transactions2
Stock Option
Direct
Converts to
Common Stock
194.05K shares
Shares
−194.05K
Strike price
Held after
0.00
Exercisable
—
12/1/2022
Stock Option
Direct
Converts to
Common Stock
10.55K shares
Shares
−10.55K
Strike price
Held after
0.00
Exercisable
—
12/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock194.05K shares | 12/1/2022 | D · Disposition | −194.05K | — | 0.00 | |
| Stock Option Direct | Common Stock10.55K shares | 12/1/2022 | D · Disposition | −10.55K | — | 0.00 |